Will Medical Compliance Ever Become Non-Voluntary?

A recent article by Dr. Lisa Rosenbaum in the New England Journal of Medicine explored both the benefits and drawbacks of Digital Adherence Monitoring. The focus was on the FDA’s recent approval of Abilify MyCite, a medicine technology that combines the medication aripiprazole, used to treat various psychiatric diseases such as schizophrenia, certain features of bipolar disorder and depression, with a digital ingestion tracking system.... // Read More »
Source: blog.bioethics.net - Category: Medical Ethics Authors: Tags: Health Care Allocation / Access / Public Health bioethics biotechnology Health Care Practice human dignity syndicated Source Type: blogs